Fundamentally, the driving catalyst for biotech stocks to buy centers on the possibility of supporting paradigm-shifting medical breakthroughs. For example, a report published by the JAMA Network indicates that experts project the global economic cost of cancers from 2020 to 2050 will be $25.2 trillion (in constant 2017 dollar terms). Therefore, finding a cure would
0 Comments
While the concept of acquiring low-PE ratio blue-chip stocks (that is, industry-leading stalwarts that feature low price-earnings ratios relative to their sectors) appeals on paper, investors need to be cautious. You can’t just buy companies based on any one single metric. In addition, sometimes a very cheap PE can actually signal significant fundamental problems. Instead,
0 Comments
Without question, tech has been the best-performing group so far in 2023. Understandably, that’s got investors looking at the best tech stocks to buy.  At the same time though, that does create a tough situation. On the one hand, investors want to stick with what’s working. The mentality of “The trend is your friend” has
0 Comments
Welcome to another week of Hypergrowth Investing, folks! With earnings season underway, we’re laser-focused on companies’ first-quarter results and what that means for stocks going forward. As we’ve mentioned previously, in the first three months of this year, both the labor market and consumer spending were quite resilient. And those two factors should support strong
0 Comments
There are multiple signs that inflation is rolling over, while consumer spending remains strong and corporate earnings are beating expectations. Meanwhile, the so-called credit crunch many investors have feared really isn’t materializing. Thus, right now may be an excellent time for investors to find high-quality stocks to buy. On the inflation front, the Producer Price
0 Comments
With Bed Bath & Beyond (NASDAQ:BBBY) facing multiple, likely insurmountable challenges, the retailer appears to be headed straight to bankruptcy. Given the tremendous volatility and unpredictable nature of the stocks of bankrupt companies, I recommend that all investors immediately sell BBBY stock. Among the seemingly insolvable problems that Bed Bath and Beyond is facing are an inability
0 Comments
There’s good news if you’re betting your investment capital on video game retailer GameStop (NYSE:GME). The company’s financials are improving, and insider buying suggests strong confidence in GME stock. Be prepared for volatility along the way, but a share position in GameStop is likely to yield excellent returns by 2025. The meme-stock traders might target
0 Comments